Skip to main content
. 2026 Sep 29;62(10):1888. doi: 10.3390/medicina62101888
CI Confidence Interval
CSS Cancer-Specific Survival
FOLFOX Folinic acid, Fluorouracil, Oxaliplatin
HR Hazard Ratio
IQR Interquartile Range
LUHS Lithuanian University of Health Sciences
MDT Multidisciplinary Team
MRI Magnetic Resonance Imaging
NR Not Reached
OS Overall Survival
pCR Pathological Complete Response
SEER Surveillance, Epidemiology, and End Results
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
TME Total Mesorectal Excision
TNT Total Neoadjuvant Treatment